November 25, 2024 November 25, 2024Categories Press ReleasesPress Release: ECOG-ACRIN adds a late-breaking abstract to its ASH 2024 presentation line-up
October 30, 2024 October 30, 2024Categories News StoriesWATCH: Behind the ECOG-ACRIN E1910 trial with lead investigator Dr. Mark Litzow
August 21, 2024 August 21, 2024Categories News StoriesHow a patient’s role in a clinical trial for acute lymphocytic leukemia brought a cancer-free diagnosis, FDA approval
August 20, 2024 August 20, 2024Categories News StoriesBlinatumomab improves 3-year overall survival in B-ALL versus chemotherapy (study E1910)
July 24, 2024 July 24, 2024Categories Press ReleasesPress Release: New England Journal of Medicine publishes practice-changing E1910 trial results
July 2, 2024 July 2, 2024Categories Announcements News StoriesThe Summer 2024 advocacy blog, Considering Clinical Trials, is now available
June 14, 2024 June 14, 2024Categories News StoriesE1910 trial leads to an FDA approval in B-cell acute lymphoblastic leukemia (B-ALL)
November 15, 2023 November 15, 2023Categories Press ReleasesPress Release: ECOG-ACRIN and PrECOG announce multiple presentations at ASH 2023
October 19, 2023 October 19, 2023Categories Announcements News StoriesThe September/October 2023 News from ECOG-ACRIN blog is now available
